Persistent CD4+ T cell hyporesponsiveness during recovery from prolonged symptomatic SARS-CoV-2 infection.

Saved in:
Bibliographic Details
Title: Persistent CD4+ T cell hyporesponsiveness during recovery from prolonged symptomatic SARS-CoV-2 infection.
Authors: Ziegler J; Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, USA., Lawrence C; Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, USA., Pezant N; Center for Biomedical Data Sciences, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, USA., Turner S; Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, USA., Redinger N; Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, USA., Guthridge C; Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, USA., Smith K; Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, USA., Chen J; Cell Cycle and Cancer Biology Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, USA., Guthridge JM; Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, USA; Department of Pathology, University of Oklahoma Health Campus, 1100 N Lindsay Ave, Oklahoma City, OK, USA., James JA; Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, USA; Department of Microbiology & Immunology, University of Oklahoma Health Campus, 1100 N Lindsay Ave, Oklahoma City, OK, USA; Department of Pathology, University of Oklahoma Health Campus, 1100 N Lindsay Ave, Oklahoma City, OK, USA., Rankin S; Cell Cycle and Cancer Biology Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, USA; Department of Cell Biology, University of Oklahoma Health Campus, 1100 N Lindsay Ave, Oklahoma City, OK, USA., Thompson LF; Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, USA; Department of Microbiology & Immunology, University of Oklahoma Health Campus, 1100 N Lindsay Ave, Oklahoma City, OK, USA., Farris AD; Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, USA; Department of Microbiology & Immunology, University of Oklahoma Health Campus, 1100 N Lindsay Ave, Oklahoma City, OK, USA; Department of Pathology, University of Oklahoma Health Campus, 1100 N Lindsay Ave, Oklahoma City, OK, USA. Electronic address: Darise-Farris@omrf.org., Kovats S; Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, USA; Department of Microbiology & Immunology, University of Oklahoma Health Campus, 1100 N Lindsay Ave, Oklahoma City, OK, USA; Department of Pathology, University of Oklahoma Health Campus, 1100 N Lindsay Ave, Oklahoma City, OK, USA. Electronic address: Susan-Kovats@omrf.org.
Source: Cellular immunology [Cell Immunol] 2026 Jun 15; Vol. 426, pp. 105127. Date of Electronic Publication: 2026 Jun 15.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 1246405 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2163 (Electronic) Linking ISSN: 00088749 NLM ISO Abbreviation: Cell Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1090-2163
DOI:10.1016/j.cellimm.2026.105127